A phase 3 trial of extended release oral dalfampridine in multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

Published:2010-10 Issue:4 Volume:68 Page:494-502
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Goodman Andrew D.,Brown Theodore R.,Edwards Keith R.,Krupp Lauren B.,Schapiro Randall T,Cohen Ron,Marinucci Lawrence N.,Blight Andrew R.,

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.22240/fullpdf

Reference22 articles.

1. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial;Goodman;Lancet,2009

2. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment;Judge;Pharmacol Ther,2006

3. 4-Aminopyridine in multiple sclerosis: prolonged administration;Stefoski;Neurology,1991

4. The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study;van Diemen;Ann Neurol,1992

Cited by 310 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial;PLOS ONE;2024-02-13

2. Performance Measures and Plasma Biomarker Levels in Patients with Multiple Sclerosis after 14 Days of Fampridine Treatment: An Explorative Study;International Journal of Molecular Sciences;2024-01-27

3. Targeting ion channels with ultra-large library screening for hit discovery;Frontiers in Molecular Neuroscience;2024-01-05

4. Task-oriented exercise effects on walking and corticospinal excitability in multiple sclerosis: protocol for a randomized controlled trial;BMC Sports Science, Medicine and Rehabilitation;2023-12-21

5. Providing meaningful interpretation of performance outcome measures by co-calibration with patient-reported outcomes through the Rasch model: illustration with multiple sclerosis measures;Journal of Biopharmaceutical Statistics;2023-11-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3